ACLX FY 2021 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$65M

Net Income

-$65M

EPS (Diluted)

$-1.94

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$60M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$129M

Total Liabilities

$250M

Stockholders' Equity

-$122M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$65M	-$32M	-102.6%
Net Income	-$65M	-$32M	-102.4%